Molecular Partners AG (MOLN)
6.77
+0.82
(+13.78%)
USD |
NASDAQ |
Jun 14, 16:00
6.69
-0.08
(-1.18%)
After-Hours: 20:00
Molecular Partners Accounts Receivable (Quarterly): 3.523M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.523M |
| December 31, 2023 | 0.3512M |
| September 30, 2023 | 1.952M |
| June 30, 2023 | 1.679M |
| March 31, 2023 | 1.909M |
| December 31, 2022 | 0.5619M |
| September 30, 2022 | 1.774M |
| June 30, 2022 | 2.703M |
| March 31, 2022 | 3.763M |
| December 31, 2021 | 25.94M |
| September 30, 2021 | 5.974M |
| June 30, 2021 | 8.591M |
| December 31, 2020 | 0.182M |
| June 30, 2020 | 2.696M |
| December 31, 2019 | 0.0237M |
| Date | Value |
|---|---|
| June 30, 2019 | 2.239M |
| June 30, 2019 | 2.239M |
| December 31, 2018 | 50.10M |
| June 30, 2018 | 1.151M |
| June 30, 2018 | 1.151M |
| December 31, 2017 | 0.1725M |
| June 30, 2017 | 1.152M |
| June 30, 2017 | 1.152M |
| December 31, 2016 | 0.0324M |
| June 30, 2016 | 1.303M |
| June 30, 2016 | 1.303M |
| December 31, 2015 | 0.8589M |
| June 30, 2015 | 16.28M |
| June 30, 2015 | 16.28M |
| December 31, 2014 | 2.884M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.0237M
Minimum
Dec 2019
25.94M
Maximum
Dec 2021
3.888M
Average
2.239M
Median
Jun 2019
Accounts Receivable (Quarterly) Benchmarks
| AC Immune SA | 0.00 |
| CRISPR Therapeutics AG | 0.00 |
| Addex Therapeutics Ltd | 0.1288M |
| NLS Pharmaceutics Ltd | -- |
| MoonLake Immunotherapeutics | -- |